RSS Parrot

BETA

🦜 Medications News - Medicine News, Health News, Medications News, Medicines, Prescriptions, Medicical Science

@medicalxpress.com.medications-news@rss-parrot.net

I'm an automated parrot! I relay a website's RSS feed to the Fediverse. Every time a new post appears in the feed, I toot about it. Follow me to get all new posts in your Mastodon timeline! Brought to you by the RSS Parrot.

---

The latest news on medicine, health, medications, medicines and prescriptions.

Your feed and you don't want it here? Just e-mail the birb.

Site URL: medicalxpress.com/medications-news/

Feed URL: medicalxpress.com/rss-feed/medications-news

Posts: 48

Followers: 1

'Pan-RAS molecular glue' is a safe and effective treatment for lung and pancreatic cancers

Published: November 20, 2026 21:40

Results from the AURORAS-1 Phase I clinical trial of an anticancer drug called ERAS-0015 have shown that it is safe and has caused tumors to shrink in hard-to-treat diseases such as lung and pancreatic cancer.

Commonly used drug kills leukemia cells early by acting mainly on RNA, not DNA

Published: November 20, 2026 15:20

For more than two decades, azacitidine has been a major treatment for blood cancers such as high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The drug was thought to work through DNA, by stripping off the chemical tags that keep…

Can psychedelics improve decision-making?

Published: November 20, 2026 14:00

For the one-in-five Americans with a mental health condition, the options for treatment aren't too much different from what they were half a century ago. Most medicines for psychiatric disorders were first pioneered in the 1950s.

Experimental anesthetic may also blunt pain at nonsedating doses

Published: November 20, 2026 13:00

Common intravenous anesthetics such as propofol and etomidate usually require additional pain medicines. Propofol and etomidate enhance GABA-A receptors, which act as brakes on nerve-cell activity, but generally do not relieve pain at nonsedating doses. In…

Blood pressure medication more likely to prevent heart attacks and strokes than cause serious falls, study finds

Published: November 20, 2026 12:40

A major study led by researchers at the Nuffield Department of Primary Care Health Sciences, University of Oxford, has found that blood pressure-lowering medication is more likely to prevent serious cardiovascular events, such as heart attacks and strokes,…

Could an erectile dysfunction drug offer a new way to treat Alzheimer's?

Published: November 20, 2026 11:40

A drug developed to treat erectile dysfunction might seem an unlikely treatment for Alzheimer's disease. But researchers are increasingly interested in whether medicines such as Viagra could also help protect the brain.

MYC inhibitor drug targets cancer cells directly and via the immune system

Published: November 20, 2026 10:00

In a series of experiments, researchers have found that an experimental MYC inhibitor drug not only targets lung cancer cells directly but also makes cancer cells easier for the immune system to target and kill.

National study highlights flexible approaches to integrating pharmacists in aged care

Published: November 20, 2026 08:20

A national study led by researchers from RMIT University and the University of Canberra (UC) has identified practical strategies to support the integration of on-site pharmacists in residential elder care homes across metropolitan, regional, rural and…

Molecular glues: Unlocking new targets in cancer

Published: November 20, 2026 07:40

The human genome encodes several hundred E3 ligases—the enzymes that decide which proteins a cell destroys. Drug developers have so far harnessed a small number of them. In a new review in Molecular Cell, researchers at Karolinska Institutet and the…

Why older adults take longer to bounce back—and what to do about it

Published: November 20, 2026 07:40

A class of fatty acid molecules called prostaglandins may be responsible for why older adults often fail to recover muscle strength after illness or injury, while young adults quickly bounce back, a new study has found. Produced by nondividing "zombie…

Possible new treatment for Wilson disease seeks to minimize effects on mitochondria using metformin

Published: November 19, 2026 17:20

Wilson disease is a rare genetic condition in which the liver loses the ability to effectively remove copper, allowing it to accumulate in the body. This toxic buildup affects the liver, brain, eyes and kidneys and is particularly bad for mitochondria, the…

Two new 16-week tuberculosis regimens advance in clinical trial

Published: November 19, 2026 13:40

Tuberculosis remains one of the world's deadliest infectious diseases, causing more than 1 million deaths each year. The development of new therapeutic regimens remains slow, costly and complex, while treatment remains lengthy and patients face the burden…

Can a small DNA fix protect against Parkinson's disease?

Published: November 19, 2026 10:40

In 2021, researchers at Oslo University Hospital discovered that by switching off a specific gene in the roundworm C. elegans, they could protect a particular type of nerve cell from age-related degeneration. These are the same types of nerve cells that…

Therapeutic antibody protects against all three pathogenic human coronaviruses

Published: November 19, 2026 09:40

A therapeutic antibody (bispecific nanobody) developed by researchers at Georgia State University and collaborators neutralized all three highly pathogenic human coronaviruses (SARS-CoV, SARS-CoV-2 and MERS-CoV) and protected animals from viral infections,…

Experimental GLS-1 inhibitor demonstrates antitumor activity in advanced treatment-resistant ovarian cancer

Published: November 19, 2026 09:40

Combining the experimental therapy IACS-6274 with targeted therapy bevacizumab and paclitaxel chemotherapy showed promising antitumor activity in a Phase I trial of patients with advanced platinum-resistant ovarian cancer, according to new results…

Experimental antibody-drug conjugate shows promising initial activity in head and neck cancers

Published: November 19, 2026 08:30

The investigational antibody-drug conjugate (ADC) micvotabart pelidotin (MICVO, PYX-201) demonstrated promising antitumor activity and a manageable safety profile in a Phase I trial presented at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer…

Antibody-drug conjugate shows promising early results in Phase I trial in sarcoma patients

Published: November 19, 2026 06:39

An antibody-drug conjugate, a type of drug that targets and enters cancer cells like a Trojan Horse, has shown promising early results across diverse types of soft tissue sarcoma in a Phase I trial. The findings were presented at the 38th EORTC-NCI-AACR…

Neurosteroid offers clues to brain changes linked to depression

Published: November 19, 2026 05:20

UT Southwestern Medical Center researchers and colleagues, including two at UT Dallas, have found evidence that pregnenolone—a naturally occurring steroid hormone the body produces from cholesterol—may alter patterns of communication between key brain…

How research paved the way for progress in a rare form of ALS

Published: November 18, 2026 19:00

An experimental ALS drug that grew out of basic and clinical research at Columbia University's Vagelos College of Physicians and Surgeons may soon become available for patients with a rare and aggressive form of the disease.

No clear benefit from two drugs intended to increase spontaneous birth after induction in first-time moms

Published: November 18, 2026 18:30

There is no clear evidence that hyoscine butylbromide or sodium bicarbonate improves spontaneous vaginal birth rates (without the assistance of forceps or vacuum) in first-time moms after induction of labor, finds a large Norwegian trial published by The…

CBD oil offers no behavioral benefit for youths with intellectual disability, new study finds

Published: November 18, 2026 15:40

Cannabis contains two key compounds that act on the brain: cannabidiol (CBD) and tetrahydrocannabinol (THC). Although both interact with the body's endocannabinoid system, the outcomes of consuming them are poles apart. THC is the compound responsible for…

Novel compound eases paralysis and activates nerve repair pathways in multiple sclerosis mouse model

Published: November 18, 2026 15:00

A new derivative of a natural compound reduced symptoms associated with multiple sclerosis and promoted the central nervous system's regenerative pathways in a mouse model, report researchers at the University of Illinois Urbana-Champaign and collaborators…

1 in 10 U.S. adults reported GLP-1 medication use July to August 2025

Published: November 18, 2026 12:00

From July to August 2025, about one in 10 U.S. adults reported taking a glucagon-like peptide-1 receptor agonist (GLP-1 RA) medication during the past year, according to research published in Morbidity and Mortality Weekly Report.

New guidance addresses GLP-1 medication use and eating disorders

Published: November 18, 2026 11:20

GLP-1 medications are widely used to treat type 2 diabetes and help some people manage their weight. These medications can reduce appetite and help people feel full sooner. Early research also suggests they may help reduce binge-eating episodes for some…

Inspired by 'Flowers for Algernon,' experimental nose drops improve memory in mice

Published: November 18, 2026 05:00

Researchers at the University of Sydney have developed experimental nose drops that enhance learning and memory in aged mice while also preventing memory loss in a mouse model of Alzheimer's disease. The treatment uses mRNA technology similar to that…

Chewable fish oil emulsion supplements may be better than soft-gel capsules

Published: November 18, 2026 03:10

In a crossover clinical trial published in the European Journal of Lipid Science and Technology, investigators found that a chewable fish oil emulsion supplement may provide higher circulating levels of omega-3 fatty acids compared with a soft gel.

Psilocybin may improve a difficult-to-treat symptom of depression, study finds

Published: November 17, 2026 22:00

New research from the University of Colorado Anschutz suggests that psilocybin may help improve anhedonia, the loss of interest or ability to experience pleasure, in people with treatment-resistant depression. In a clinical trial, researchers found…

FDA approves first factor XIa inhibitor for secondary stroke prevention

Published: November 17, 2026 21:20

The U.S. Food and Drug Administration has approved Sunharbo (asundexian) 50 mg tablets, in combination with antiplatelet therapy, to reduce the risk for stroke in adults following a recent mild-to-moderate noncardioembolic ischemic stroke or a high-risk…

GLP-1 weight-loss drugs linked to inadequate intake of key nutrients in some people

Published: November 17, 2026 18:30

Drugs taken to suppress appetite, such as Wegovy and Mounjaro, are associated with inadequate intakes of key nutrients and energy in some people, finds a small exploratory study published in the journal BMJ Nutrition Prevention & Health.

First evidence from a Chinese population supports review of long-term blood monitoring for local clozapine use

Published: November 17, 2026 18:20

An international research team led by the Department of Psychiatry, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has completed a long-term population-based research study to improve care for people with…

First successful human challenge model for dengue serotype 4 could speed vaccine and drug testing

Published: November 17, 2026 16:20

Researchers at the University of Maryland School of Medicine (UMSOM) and the Institute of Human Virology (IHV) have developed the first successful human challenge model for dengue serotype 4, a major advance that could speed the development of new drugs…

Five things that shape body weight—by an obesity expert

Published: November 17, 2026 14:30

What you eat when you're tired and hungry might come down to what's open on the way home and what you can afford. Both appetite and access to food shape decisions that can look, from the outside, like simple matters of choice.

Increasing methadone doses associated with improved quality of life

Published: November 17, 2026 10:20

The introduction of fentanyl, a potent synthetic opioid, into the U.S. drug supply has remade the landscape for health and recovery. This includes changing norms around the use of methadone, a common treatment option for opioid use disorder.

New SARS-CoV-2 variant PJ.2.1: Vaccine antibodies provide protection

Published: November 17, 2026 09:00

Germany's COVID-19 traffic light is red, and the number of infections is high. But how well is the population protected against the virus variants currently circulating? The new SARS-CoV-2 variant PJ.2.1 has been spreading since May and has long since…

Tirzepatide moves more than half of treated teens below obesity threshold, new clinical trial reports

Published: November 17, 2026 08:30

Tirzepatide (Zepbound) is a once-weekly injectable medication that hits two targets at once. This dual-action drug mimics the effects of two natural gut hormones in the body—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1…

Researchers find potential way to protect the brain from HIV and opioid damage

Published: November 16, 2026 15:40

People living with HIV continue to struggle with memory loss, difficulty concentrating and poor decision-making, even as antiretroviral treatments have dramatically improved life expectancy. For patients who also use opioids—which may be prescribed to…

Astaxanthin supplements: What the science says about skin, exercise and your brain

Published: November 16, 2026 13:40

Smoother skin, sharper eyesight, better memory, stronger joints, improved athletic performance and even protection against aging—astaxanthin is marketed as a supplement with an extraordinary range of health benefits. But how much of this promise is backed…

This time, the virus is on the patient's side. AI helped design it

Published: November 16, 2026 13:40

AI can write emails, create seasoning blends or put pets in Renaissance outfits. One adventurous baker used ChatGPT to concoct a cake from sauerkraut and seaweed. Now, there's an AI-made virus on the scene.

Beyond DMT: Why the true power of Brazil's sacred jurema plant is social, not just psychedelic

Published: November 16, 2026 12:00

Jurema-preta is the name of both a plant—Mimosa tenuiflora—and an Indigenous spiritual tradition of northeastern Brazil. The plant is used to make a potentially hallucinogenic brew that is consumed in sacred rituals. The exact mixture of herbs and other…

Ending Medicaid coverage for weight-loss drugs linked to sharp drop in GLP-1 use

Published: November 16, 2026 11:00

Medicaid prescriptions for weight loss–approved GLP-1 medications fell sharply after four states ended coverage of the drugs, according to a new study led by researchers at the University of Pittsburgh. The findings, published in JAMA, demonstrate how…

HIV drug lenacapavir found to disrupt virus formation, creating giant noninfectious particles

Published: November 16, 2026 09:20

Lenacapavir is a powerful, long-acting drug used to prevent and treat HIV infection. While it is known to block key steps in the virus's replication after entering a cell, researchers have now uncovered another way the drug works: it disrupts the formation…

Weekly weight-loss injection combo shows promise

Published: November 16, 2026 07:40

Two lower doses of CagriSema, a weekly injection combining two appetite-reducing medicines, cagrilintide and semaglutide, led to substantial weight loss in adults with obesity or with overweight and a weight-related health condition such as high blood…